Related Experiment Video
Updated: Sep 26, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Primary Aldosteronism: Reassessing Underdiagnosis, Overdiagnosis, and Clinical Decision-Making
Gamze Akkus1, Aslı Boz2, Tamer Tetiker1
1Cukurova University, Faculty of Medicine, Division of Endocrinology, Adana, Turkey.
Abstract:
Primary Aldosteronism (PA) is postulated to represent one of the most prevalent and significant etiologies of secondary hypertension. A majority of investigations have indicated that the incidence of PA has been escalating, particularly within the cohort of normokalemic individuals. PA generally constitutes an adrenal pathology characterized by excessive production of aldosterone, which may occur bilaterally or unilaterally. The evaluation for Primary Aldosteronism (PA) is alarmingly inadequate, frequently postponed until a substantial duration after the identification of hypertension, generally occurring after the onset of significant adverse health outcomes. This situation may, in part, stem from prevalent misconceptions that PA exists solely in conjunction with hypokalemia, adrenal macro-nodules, markedly elevated levels of aldosterone, or severely elevated blood pressure. Despite the effective methods for diagnosing and treating PA, it remains markedly underdiagnosed and undertreated. The screening and diagnosis of Primary Aldosteronism represent a critical advancement for the timely management of the condition; however, it can occasionally pose significant challenges for healthcare professionals. As a screening methodology, the plasma aldosterone concentration to renin ratio continues to serve as a pragmatic and dependable indicator, acknowledging that aldosterone levels are affected by numerous confounding variables, including ethnicity, gender, pharmacological agents, and the timing of measurements. This review aimed to highlight the optimal conditions for measuring plasma aldosterone levels and discuss who should undergo PA screening and when. It also aims to critically reassess clinical outcomes, diagnostic methodologies, and treatment strategies related to Primary Aldosteronism through the presentation of a detailed case report. Furthermore, this review emphasizes the diagnostic methodologies that should be prioritized in clinical practice by elucidating a specific case.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cushing Syndrome I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Errors occurring during blood pressure monitoring
Several factors...